FBLG
FibroBiologics, Inc. Common Stock
1W: -3.7%
1M: -6.2%
3M: -3.4%
YTD: +4.5%
1Y: -77.4%
$0.26
+0.01 (+2.41%)
After Hours: $0.23 (-0.03, -13.19%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$11.0M
52W Range0.22-1.53
Volume1,012,431
Avg Volume1,692,862
Beta-0.67
Dividend—
Analyst Ratings
Company Info
CEOPeter O'Heeron
Employees13
SectorHealthcare
IndustryBiotechnology
IPO Date2024-02-01
Websitefibrobiologics.com
455 East Medical Center Boulevard
Houston, DE 77598
US
Houston, DE 77598
US
281 651 5150
About FibroBiologics, Inc. Common Stock
FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the treatment of degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for wound healing. The company is also on the early-stage research of CYTER915, which is designed to regenerate or reinvigorate production of the thymus and/or spleen; CYPS317, for the treatment of psoriasis; and TCB190 to treat certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.
Latest News
12 Health Care Stocks Moving In Wednesday's After-Market Session
Stocks to watch after market on Wednesday: DRVN, EGO, FBLG
FibroBiologics to implement 1-for-20 reverse stock split to meet Nasdaq requirement
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Khoja Hamid | P-Purchase | 30,000 | $0.38 | 2026-03-04 |
| O'HEERON PETE | P-Purchase | 15,872 | $0.38 | 2026-03-04 |
| O'HEERON PETE | P-Purchase | 18,200 | $0.41 | 2026-03-03 |
| O'HEERON PETE | P-Purchase | 17,428 | $0.35 | 2026-03-02 |
| Davis Jason | P-Purchase | 70,000 | $0.41 | 2026-03-02 |